Pain medicine

Comparison of three different methods of postoperative analgesic effects in laparoscopic major liver resection (systemic analgesia vs. erector spinae plane block vs. quadratus lumborum block): A randomized controlled trial

J Clin AnesthPublished Randomised controlled trial

Authors' conclusion

Neither ESPB nor posterior QLB resulted in a significant decrease in cumulative opioid consumption within 24 h after laparoscopic major liver resection.

Study context

Population
Patients undergoing laparoscopic major liver resection
Participants
114 patients
Comparison
Single-shot ESP block or posterior QL block (40 mL 0.5% ropivacaine) plus systemic analgesia vs systemic analgesia alone
Primary endpoint
Cumulative opioid consumption
Follow-up
24 h post-surgery
Methodological detailssingle-centre, three-arm (1:1:1), August 2022 to January 2024
  • Single-centre
  • Three-arm (1:1:1)
  • August 2022 to January 2024

Primary result

As reported in the abstract

adjP > 0.99

Secondary outcomes

Cumulative opioid consumption at 1 and 48 h

No significant difference among the three groups at 1 h
adjP = 0.336
No significant difference among the three groups at 48 h
0.732

Cumulative opioid consumption at 72 h · 72 h post-surgery

Significantly lower at 72 h
adjP = 0.032

Pain at rest and when coughing

Pain at rest lower in erector spinae plane block (ESPB) and quadratus lumborum block (QLB) vs control during postanesthesia care unit (PACU) stay and at 48 h
Pain when coughing reduced in both block groups only during PACU stay

Original publication

Comparison of three different methods of postoperative analgesic effects in laparoscopic major liver resection (systemic analgesia vs. erector spinae plane block vs. quadratus lumborum block): A randomized controlled trial. J Clin Anesth. Published 14 October 2025. doi:10.1016/j.jclinane.2025.112019

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.